Stem definition | Drug id | CAS RN |
---|---|---|
prednisone and prednisolone derivatives | 294 | 5534-09-8 |
Dose | Unit | Route |
---|---|---|
0.40 | mg | N |
0.80 | mg | Inhal.aerosol |
0.80 | mg | Inhal.powder |
1.50 | mg | Inhal.solution |
Property | Value | Reference |
---|---|---|
MRTD (Maximum Recommended Therapeutic Daily Dose) | 0.05 ยตM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
Vd (Volume of distribution) | 0.29 L/kg | Lombardo F, Berellini G, Obach RS |
CL (Clearance) | 36 mL/min/kg | Lombardo F, Berellini G, Obach RS |
fu (Fraction unbound in plasma) | 0.13 % | Lombardo F, Berellini G, Obach RS |
t_half (Half-life) | 0.50 hours | Lombardo F, Berellini G, Obach RS |
Date | Agency | Company | Orphan |
---|---|---|---|
May 12, 1976 | FDA |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Asthma | 366.04 | 12.32 | 304 | 21363 | 89033 | 50494424 |
Wheezing | 167.03 | 12.32 | 167 | 21500 | 61880 | 50521577 |
Dyspnoea | 87.04 | 12.32 | 462 | 21205 | 547146 | 50036311 |
Drug ineffective | 70.10 | 12.32 | 155 | 21512 | 819178 | 49764279 |
Lip swelling | 67.26 | 12.32 | 67 | 21600 | 24669 | 50558788 |
Chest discomfort | 66.49 | 12.32 | 132 | 21535 | 92590 | 50490867 |
Depressed mood | 65.87 | 12.32 | 77 | 21590 | 33946 | 50549511 |
Cough | 61.86 | 12.32 | 235 | 21432 | 241029 | 50342428 |
Swelling face | 61.53 | 12.32 | 93 | 21574 | 52502 | 50530955 |
Nightmare | 60.06 | 12.32 | 52 | 21615 | 16034 | 50567423 |
Swollen tongue | 55.76 | 12.32 | 65 | 21602 | 28565 | 50554892 |
Bronchospasm | 55.42 | 12.32 | 48 | 21619 | 14806 | 50568651 |
Rheumatoid arthritis | 53.14 | 12.32 | 11 | 21656 | 202539 | 50380918 |
Asthmatic crisis | 44.51 | 12.32 | 19 | 21648 | 1609 | 50581848 |
Contraindicated product administered | 43.67 | 12.32 | 6 | 21661 | 148952 | 50434505 |
Systemic lupus erythematosus | 42.84 | 12.32 | 5 | 21662 | 140617 | 50442840 |
Blood electrolytes abnormal | 42.79 | 12.32 | 16 | 21651 | 957 | 50582500 |
Malaise | 42.50 | 12.32 | 267 | 21400 | 335265 | 50248192 |
Toxicity to various agents | 42.35 | 12.32 | 19 | 21648 | 212480 | 50370977 |
Death | 41.44 | 12.32 | 47 | 21620 | 325332 | 50258125 |
Treatment failure | 39.29 | 12.32 | 6 | 21661 | 137631 | 50445826 |
Periorbital swelling | 38.77 | 12.32 | 18 | 21649 | 1859 | 50581598 |
Transient ischaemic attack | 37.72 | 12.32 | 57 | 21610 | 32153 | 50551304 |
Infusion related reaction | 37.32 | 12.32 | 13 | 21654 | 169544 | 50413913 |
Separation anxiety disorder | 37.12 | 12.32 | 7 | 21660 | 23 | 50583434 |
Arthropathy | 36.71 | 12.32 | 11 | 21656 | 157895 | 50425562 |
Flashback | 36.30 | 12.32 | 9 | 21658 | 129 | 50583328 |
Bronchial secretion retention | 35.96 | 12.32 | 16 | 21651 | 1497 | 50581960 |
Middle insomnia | 34.88 | 12.32 | 31 | 21636 | 9890 | 50573567 |
Sputum discoloured | 34.06 | 12.32 | 35 | 21632 | 13360 | 50570097 |
Anaphylactic reaction | 34.06 | 12.32 | 73 | 21594 | 53982 | 50529475 |
Throat tightness | 33.56 | 12.32 | 43 | 21624 | 20804 | 50562653 |
Squamous cell carcinoma of the oral cavity | 33.52 | 12.32 | 10 | 21657 | 295 | 50583162 |
Nonspecific reaction | 33.48 | 12.32 | 16 | 21651 | 1763 | 50581694 |
Paraesthesia oral | 33.02 | 12.32 | 33 | 21634 | 12188 | 50571269 |
Productive cough | 33.01 | 12.32 | 71 | 21596 | 52623 | 50530834 |
Eosinophilic granulomatosis with polyangiitis | 32.05 | 12.32 | 16 | 21651 | 1939 | 50581518 |
Aggression | 31.57 | 12.32 | 42 | 21625 | 21074 | 50562383 |
Bacterial disease carrier | 30.86 | 12.32 | 12 | 21655 | 799 | 50582658 |
Infective pulmonary exacerbation of cystic fibrosis | 30.40 | 12.32 | 26 | 21641 | 7883 | 50575574 |
Dizziness | 30.16 | 12.32 | 252 | 21415 | 346117 | 50237340 |
Obstructive airways disorder | 29.58 | 12.32 | 35 | 21632 | 15617 | 50567840 |
Anxiety | 29.45 | 12.32 | 152 | 21515 | 177454 | 50406003 |
Miller Fisher syndrome | 29.08 | 12.32 | 7 | 21660 | 88 | 50583369 |
Drug monitoring procedure not performed | 29.08 | 12.32 | 10 | 21657 | 469 | 50582988 |
Pharyngeal swelling | 28.47 | 12.32 | 20 | 21647 | 4546 | 50578911 |
Abdominal rigidity | 28.09 | 12.32 | 14 | 21653 | 1690 | 50581767 |
Off label use | 27.12 | 12.32 | 108 | 21559 | 474318 | 50109139 |
Limb injury | 26.84 | 12.32 | 38 | 21629 | 20212 | 50563245 |
Rash macular | 26.78 | 12.32 | 37 | 21630 | 19240 | 50564217 |
Arterial spasm | 26.27 | 12.32 | 6 | 21661 | 59 | 50583398 |
Differential white blood cell count abnormal | 25.39 | 12.32 | 10 | 21657 | 689 | 50582768 |
Dermatitis allergic | 24.96 | 12.32 | 29 | 21638 | 12691 | 50570766 |
Dysmetropsia | 24.96 | 12.32 | 6 | 21661 | 75 | 50583382 |
Sinusitis | 24.90 | 12.32 | 141 | 21526 | 170417 | 50413040 |
Forced expiratory volume decreased | 24.54 | 12.32 | 18 | 21649 | 4376 | 50579081 |
Gastric mucosa erythema | 24.38 | 12.32 | 7 | 21660 | 180 | 50583277 |
Eye movement disorder | 24.00 | 12.32 | 18 | 21649 | 4527 | 50578930 |
Sleep disorder due to a general medical condition | 23.88 | 12.32 | 22 | 21645 | 7349 | 50576108 |
Abdominal discomfort | 23.86 | 12.32 | 39 | 21628 | 231602 | 50351855 |
Glossodynia | 23.53 | 12.32 | 10 | 21657 | 115559 | 50467898 |
Breast conserving surgery | 23.46 | 12.32 | 10 | 21657 | 844 | 50582613 |
Palpitations | 23.27 | 12.32 | 91 | 21576 | 94415 | 50489042 |
Pregnancy with implant contraceptive | 23.08 | 12.32 | 13 | 21654 | 2010 | 50581447 |
Angioplasty | 22.75 | 12.32 | 11 | 21656 | 1244 | 50582213 |
Oropharyngeal pain | 22.58 | 12.32 | 79 | 21588 | 77722 | 50505735 |
Idiopathic orbital inflammation | 22.18 | 12.32 | 6 | 21661 | 123 | 50583334 |
Secretion discharge | 20.35 | 12.32 | 23 | 21644 | 9768 | 50573689 |
Superinfection | 20.23 | 12.32 | 12 | 21655 | 2044 | 50581413 |
Urticaria | 20.16 | 12.32 | 109 | 21558 | 129452 | 50454005 |
Bronchitis | 20 | 12.32 | 93 | 21574 | 104066 | 50479391 |
Gingival swelling | 19.97 | 12.32 | 15 | 21652 | 3780 | 50579677 |
Essential tremor | 19.83 | 12.32 | 9 | 21658 | 882 | 50582575 |
Sinus operation | 19.63 | 12.32 | 11 | 21656 | 1685 | 50581772 |
Facial pain | 19.56 | 12.32 | 20 | 21647 | 7589 | 50575868 |
Choking | 19.46 | 12.32 | 21 | 21646 | 8477 | 50574980 |
Hiccups | 19.37 | 12.32 | 11 | 21656 | 1728 | 50581729 |
Hyponatraemia | 19.32 | 12.32 | 87 | 21580 | 96052 | 50487405 |
Anger | 19.23 | 12.32 | 24 | 21643 | 11309 | 50572148 |
Therapeutic product effect decreased | 19.15 | 12.32 | 18 | 21649 | 136032 | 50447425 |
Gastroenteritis aeromonas | 19.11 | 12.32 | 4 | 21663 | 25 | 50583432 |
Peripheral vascular disorder | 19.05 | 12.32 | 17 | 21650 | 5450 | 50578007 |
Myalgia | 18.95 | 12.32 | 104 | 21563 | 124215 | 50459242 |
Rhinovirus infection | 18.67 | 12.32 | 14 | 21653 | 3520 | 50579937 |
Hepatic enzyme increased | 18.39 | 12.32 | 19 | 21648 | 137361 | 50446096 |
Tongue pruritus | 18.37 | 12.32 | 7 | 21660 | 441 | 50583016 |
Migraine | 18.14 | 12.32 | 72 | 21595 | 75208 | 50508249 |
Drug intolerance | 18.12 | 12.32 | 42 | 21625 | 219062 | 50364395 |
Nail infection | 18.04 | 12.32 | 11 | 21656 | 1970 | 50581487 |
Nasal discomfort | 17.43 | 12.32 | 14 | 21653 | 3890 | 50579567 |
Status asthmaticus | 17.24 | 12.32 | 8 | 21659 | 825 | 50582632 |
Brain contusion | 17.08 | 12.32 | 7 | 21660 | 535 | 50582922 |
Discomfort | 16.89 | 12.32 | 13 | 21654 | 108367 | 50475090 |
Alopecia | 16.48 | 12.32 | 52 | 21615 | 244995 | 50338462 |
Drug abuse | 16.20 | 12.32 | 3 | 21664 | 59843 | 50523614 |
Respiration abnormal | 16.09 | 12.32 | 15 | 21652 | 5087 | 50578370 |
Musculoskeletal stiffness | 15.84 | 12.32 | 19 | 21648 | 128462 | 50454995 |
Antipsychotic drug level increased | 15.72 | 12.32 | 12 | 21655 | 3097 | 50580360 |
Derealisation | 15.51 | 12.32 | 8 | 21659 | 1038 | 50582419 |
Pain | 15.47 | 12.32 | 166 | 21501 | 578737 | 50004720 |
Oral mucosa erosion | 15.45 | 12.32 | 8 | 21659 | 1047 | 50582410 |
Urinary incontinence | 15.41 | 12.32 | 36 | 21631 | 28172 | 50555285 |
Malignant neoplasm progression | 15.36 | 12.32 | 5 | 21662 | 68119 | 50515338 |
Skin exfoliation | 15.30 | 12.32 | 40 | 21627 | 33572 | 50549885 |
Bladder irritation | 15.18 | 12.32 | 5 | 21662 | 205 | 50583252 |
Cytomegalovirus enteritis | 14.78 | 12.32 | 5 | 21662 | 223 | 50583234 |
Tendonitis | 14.72 | 12.32 | 26 | 21641 | 16679 | 50566778 |
Pneumonia streptococcal | 14.71 | 12.32 | 9 | 21658 | 1622 | 50581835 |
Reperfusion arrhythmia | 14.55 | 12.32 | 5 | 21662 | 234 | 50583223 |
Necrosis ischaemic | 14.47 | 12.32 | 7 | 21660 | 792 | 50582665 |
Lacrimation increased | 14.40 | 12.32 | 26 | 21641 | 16966 | 50566491 |
Product dosage form issue | 13.80 | 12.32 | 3 | 21664 | 23 | 50583434 |
Skin fragility | 13.80 | 12.32 | 6 | 21661 | 531 | 50582926 |
Anaemia | 13.43 | 12.32 | 59 | 21608 | 252397 | 50331060 |
Headache | 13.40 | 12.32 | 297 | 21370 | 506238 | 50077219 |
Platelet count decreased | 13.40 | 12.32 | 14 | 21653 | 100712 | 50482745 |
Poor peripheral circulation | 13.26 | 12.32 | 11 | 21656 | 3197 | 50580260 |
Mobility decreased | 13.22 | 12.32 | 9 | 21658 | 79939 | 50503518 |
Hyperkinesia | 13.06 | 12.32 | 8 | 21659 | 1444 | 50582013 |
Oral mucosal blistering | 13.01 | 12.32 | 13 | 21654 | 4799 | 50578658 |
Product administered to patient of inappropriate age | 12.97 | 12.32 | 10 | 21657 | 2620 | 50580837 |
Nasal discharge discolouration | 12.75 | 12.32 | 8 | 21659 | 1506 | 50581951 |
Joint swelling | 12.64 | 12.32 | 58 | 21609 | 245228 | 50338229 |
Lethargy | 12.49 | 12.32 | 48 | 21619 | 49384 | 50534073 |
Stomatitis | 12.48 | 12.32 | 15 | 21652 | 101329 | 50482128 |
Acute myocardial infarction | 12.48 | 12.32 | 34 | 21633 | 29239 | 50554218 |
Angioedema | 12.47 | 12.32 | 40 | 21627 | 37636 | 50545821 |
Helicobacter infection | 12.41 | 12.32 | 3 | 21664 | 49699 | 50533758 |
Viral haemorrhagic cystitis | 12.34 | 12.32 | 6 | 21661 | 687 | 50582770 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Asthma | 298.36 | 12.95 | 185 | 12733 | 33664 | 29527945 |
Wheezing | 135.83 | 12.95 | 114 | 12804 | 33126 | 29528483 |
Dyspnoea | 78.28 | 12.95 | 315 | 12603 | 326417 | 29235192 |
Sleep terror | 75.41 | 12.95 | 23 | 12895 | 718 | 29560891 |
Lip swelling | 62.18 | 12.95 | 48 | 12870 | 12362 | 29549247 |
Ballismus | 60.41 | 12.95 | 12 | 12906 | 54 | 29561555 |
Anger | 58.70 | 12.95 | 44 | 12874 | 10846 | 29550763 |
Nightmare | 56.85 | 12.95 | 44 | 12874 | 11373 | 29550236 |
Swollen tongue | 51.97 | 12.95 | 43 | 12875 | 12223 | 29549386 |
Blood immunoglobulin E increased | 44.02 | 12.95 | 20 | 12898 | 1927 | 29559682 |
Lower respiratory tract infection | 43.93 | 12.95 | 56 | 12862 | 26446 | 29535163 |
Pharyngeal oedema | 42.12 | 12.95 | 28 | 12890 | 5706 | 29555903 |
Infective pulmonary exacerbation of cystic fibrosis | 39.99 | 12.95 | 28 | 12890 | 6208 | 29555401 |
Malaise | 37.25 | 12.95 | 153 | 12765 | 159449 | 29402160 |
Attention-seeking behaviour | 33.85 | 12.95 | 7 | 12911 | 40 | 29561569 |
Nasal disorder | 33.12 | 12.95 | 15 | 12903 | 1434 | 29560175 |
Abnormal behaviour | 32.38 | 12.95 | 45 | 12873 | 23082 | 29538527 |
Acquired macroglossia | 32.11 | 12.95 | 6 | 12912 | 18 | 29561591 |
Anosmia | 31.47 | 12.95 | 16 | 12902 | 1975 | 29559634 |
Chest discomfort | 29.18 | 12.95 | 63 | 12855 | 45920 | 29515689 |
Neuropsychiatric symptoms | 28.58 | 12.95 | 10 | 12908 | 484 | 29561125 |
Chorea | 28.42 | 12.95 | 12 | 12906 | 969 | 29560640 |
Cough | 26.83 | 12.95 | 118 | 12800 | 126609 | 29435000 |
Dyspnoea at rest | 26.81 | 12.95 | 17 | 12901 | 3197 | 29558412 |
Nasal discomfort | 25.99 | 12.95 | 12 | 12906 | 1200 | 29560409 |
Sputum discoloured | 25.71 | 12.95 | 22 | 12896 | 6541 | 29555068 |
Central obesity | 25.05 | 12.95 | 9 | 12909 | 471 | 29561138 |
Daydreaming | 25.01 | 12.95 | 9 | 12909 | 473 | 29561136 |
Neonatal hyponatraemia | 24.99 | 12.95 | 6 | 12912 | 73 | 29561536 |
Toxicity to various agents | 24.34 | 12.95 | 24 | 12894 | 173637 | 29387972 |
Crepitations | 24.14 | 12.95 | 15 | 12903 | 2724 | 29558885 |
Death | 23.64 | 12.95 | 74 | 12844 | 342010 | 29219599 |
Crying | 23.16 | 12.95 | 19 | 12899 | 5332 | 29556277 |
Gastric ulcer perforation | 22.98 | 12.95 | 10 | 12908 | 870 | 29560739 |
Paraesthesia oral | 22.96 | 12.95 | 16 | 12902 | 3521 | 29558088 |
Gastrointestinal tract irritation | 22.75 | 12.95 | 7 | 12911 | 225 | 29561384 |
Micturition urgency | 21.62 | 12.95 | 18 | 12900 | 5155 | 29556454 |
Productive cough | 21.18 | 12.95 | 44 | 12874 | 31215 | 29530394 |
Neuropsychiatric syndrome | 20.89 | 12.95 | 5 | 12913 | 60 | 29561549 |
Spleen congestion | 20.78 | 12.95 | 7 | 12911 | 302 | 29561307 |
Cervicogenic headache | 20.72 | 12.95 | 4 | 12914 | 15 | 29561594 |
Chronic obstructive pulmonary disease | 20.36 | 12.95 | 51 | 12867 | 40904 | 29520705 |
Completed suicide | 20.36 | 12.95 | 7 | 12911 | 90239 | 29471370 |
Palpitations | 19.91 | 12.95 | 44 | 12874 | 32560 | 29529049 |
Bronchomalacia | 19.11 | 12.95 | 5 | 12913 | 88 | 29561521 |
Eye swelling | 18.80 | 12.95 | 21 | 12897 | 8636 | 29552973 |
Mesothelioma | 18.79 | 12.95 | 7 | 12911 | 406 | 29561203 |
Depressed mood | 18.67 | 12.95 | 29 | 12889 | 16419 | 29545190 |
Benign prostatic hyperplasia | 18.23 | 12.95 | 24 | 12894 | 11686 | 29549923 |
Mood swings | 18.22 | 12.95 | 19 | 12899 | 7232 | 29554377 |
Locked-in syndrome | 18.13 | 12.95 | 6 | 12912 | 245 | 29561364 |
Suicidal ideation | 18.07 | 12.95 | 44 | 12874 | 34672 | 29526937 |
Malignant neoplasm progression | 17.97 | 12.95 | 5 | 12913 | 73854 | 29487755 |
Nasal septum perforation | 17.80 | 12.95 | 5 | 12913 | 116 | 29561493 |
Platelet count decreased | 17.71 | 12.95 | 12 | 12906 | 104660 | 29456949 |
Self-injurious ideation | 17.60 | 12.95 | 10 | 12908 | 1541 | 29560068 |
Convulsive threshold lowered | 17.45 | 12.95 | 7 | 12911 | 496 | 29561113 |
Angioedema | 17.20 | 12.95 | 41 | 12877 | 31874 | 29529735 |
Antibody test abnormal | 17.05 | 12.95 | 5 | 12913 | 136 | 29561473 |
Multifocal motor neuropathy | 17.03 | 12.95 | 4 | 12914 | 44 | 29561565 |
Rash papular | 16.71 | 12.95 | 19 | 12899 | 7962 | 29553647 |
Hepatic cancer | 16.37 | 12.95 | 17 | 12901 | 6439 | 29555170 |
Aortic dissection | 15.98 | 12.95 | 11 | 12907 | 2373 | 29559236 |
Urticaria | 15.66 | 12.95 | 56 | 12862 | 54604 | 29507005 |
Renal aplasia | 15.56 | 12.95 | 7 | 12911 | 659 | 29560950 |
Anaphylactic reaction | 15.49 | 12.95 | 36 | 12882 | 27537 | 29534072 |
Tryptase increased | 15.32 | 12.95 | 5 | 12913 | 195 | 29561414 |
Thrombocytopenia | 15.28 | 12.95 | 22 | 12896 | 134801 | 29426808 |
Sinusitis | 15.25 | 12.95 | 41 | 12877 | 34309 | 29527300 |
Ageusia | 14.98 | 12.95 | 19 | 12899 | 8919 | 29552690 |
Product administered to patient of inappropriate age | 14.91 | 12.95 | 11 | 12907 | 2644 | 29558965 |
Headache | 14.83 | 12.95 | 128 | 12790 | 173879 | 29387730 |
Renal failure | 14.82 | 12.95 | 18 | 12900 | 118581 | 29443028 |
Eosinophilia | 14.78 | 12.95 | 31 | 12887 | 22130 | 29539479 |
Obstructive airways disorder | 14.77 | 12.95 | 21 | 12897 | 10995 | 29550614 |
Weaning failure | 14.75 | 12.95 | 5 | 12913 | 220 | 29561389 |
Ejaculation failure | 14.61 | 12.95 | 7 | 12911 | 760 | 29560849 |
Nasal inflammation | 14.53 | 12.95 | 5 | 12913 | 230 | 29561379 |
Neonatal seizure | 14.29 | 12.95 | 6 | 12912 | 478 | 29561131 |
Ocular discomfort | 14.25 | 12.95 | 9 | 12909 | 1680 | 29559929 |
Violence-related symptom | 14.02 | 12.95 | 6 | 12912 | 501 | 29561108 |
Infarction | 13.51 | 12.95 | 10 | 12908 | 2416 | 29559193 |
Apnoeic attack | 13.15 | 12.95 | 5 | 12913 | 307 | 29561302 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Asthma | 516.24 | 11.63 | 395 | 29555 | 94830 | 64373952 |
Wheezing | 263.01 | 11.63 | 250 | 29700 | 80329 | 64388453 |
Dyspnoea | 134.03 | 11.63 | 672 | 29278 | 718002 | 63750780 |
Lip swelling | 127.51 | 11.63 | 111 | 29839 | 31796 | 64436986 |
Nightmare | 124.38 | 11.63 | 92 | 29858 | 20901 | 64447881 |
Swollen tongue | 105.54 | 11.63 | 104 | 29846 | 34850 | 64433932 |
Depressed mood | 88.34 | 11.63 | 102 | 29848 | 40910 | 64427872 |
Sleep terror | 82.31 | 11.63 | 28 | 29922 | 1169 | 64467613 |
Completed suicide | 81.24 | 11.63 | 6 | 29944 | 224408 | 64244374 |
Chest discomfort | 77.08 | 11.63 | 168 | 29782 | 115938 | 64352844 |
Swelling face | 74.40 | 11.63 | 113 | 29837 | 59053 | 64409729 |
Anger | 73.67 | 11.63 | 60 | 29890 | 15681 | 64453101 |
Malaise | 73.06 | 11.63 | 370 | 29580 | 395877 | 64072905 |
Toxicity to various agents | 68.64 | 11.63 | 42 | 29908 | 363471 | 64105311 |
Drug ineffective | 66.33 | 11.63 | 187 | 29763 | 840060 | 63628722 |
Infective pulmonary exacerbation of cystic fibrosis | 63.88 | 11.63 | 49 | 29901 | 11747 | 64457035 |
Death | 59.02 | 11.63 | 83 | 29867 | 482622 | 63986160 |
Sputum discoloured | 55.51 | 11.63 | 54 | 29896 | 17802 | 64450980 |
Cough | 53.41 | 11.63 | 279 | 29671 | 301869 | 64166913 |
Paraesthesia oral | 51.07 | 11.63 | 45 | 29905 | 13086 | 64455696 |
Bronchospasm | 48.49 | 11.63 | 55 | 29895 | 21627 | 64447155 |
Drug abuse | 46.59 | 11.63 | 4 | 29946 | 132370 | 64336412 |
Ballismus | 46.31 | 11.63 | 12 | 29938 | 190 | 64468592 |
Dizziness | 45.87 | 11.63 | 349 | 29601 | 429814 | 64038968 |
Pharyngeal oedema | 44.63 | 11.63 | 45 | 29905 | 15486 | 64453296 |
Rheumatoid arthritis | 44.06 | 11.63 | 11 | 29939 | 164283 | 64304499 |
Separation anxiety disorder | 41.84 | 11.63 | 8 | 29942 | 26 | 64468756 |
Asthmatic crisis | 41.64 | 11.63 | 19 | 29931 | 1737 | 64467045 |
Productive cough | 40.89 | 11.63 | 99 | 29851 | 73104 | 64395678 |
Periorbital swelling | 40.44 | 11.63 | 19 | 29931 | 1857 | 64466925 |
Palpitations | 40.03 | 11.63 | 123 | 29827 | 104365 | 64364417 |
Infusion related reaction | 38.68 | 11.63 | 14 | 29936 | 164453 | 64304329 |
Treatment failure | 37.36 | 11.63 | 5 | 29945 | 116811 | 64351971 |
Abnormal behaviour | 36.42 | 11.63 | 60 | 29890 | 33562 | 64435220 |
Obstructive airways disorder | 36.05 | 11.63 | 49 | 29901 | 23136 | 64445646 |
Eosinophilic granulomatosis with polyangiitis | 35.43 | 11.63 | 20 | 29930 | 2862 | 64465920 |
Transient ischaemic attack | 35.25 | 11.63 | 69 | 29881 | 44113 | 64424669 |
Off label use | 35.08 | 11.63 | 163 | 29787 | 632643 | 63836139 |
Anxiety | 34.30 | 11.63 | 185 | 29765 | 202464 | 64266318 |
Aggression | 34.24 | 11.63 | 70 | 29880 | 46162 | 64422620 |
Malignant neoplasm progression | 33.44 | 11.63 | 6 | 29944 | 112865 | 64355917 |
Crepitations | 32.54 | 11.63 | 28 | 29922 | 7887 | 64460895 |
Rash macular | 32.28 | 11.63 | 47 | 29903 | 23638 | 64445144 |
Synovitis | 32.27 | 11.63 | 4 | 29946 | 99086 | 64369696 |
Blood electrolytes abnormal | 32.15 | 11.63 | 16 | 29934 | 1775 | 64467007 |
Attention-seeking behaviour | 32.06 | 11.63 | 8 | 29942 | 108 | 64468674 |
Contraindicated product administered | 31.37 | 11.63 | 6 | 29944 | 107823 | 64360959 |
Anaphylactic reaction | 31.27 | 11.63 | 86 | 29864 | 68578 | 64400204 |
Middle insomnia | 31.09 | 11.63 | 34 | 29916 | 12843 | 64455939 |
Bacterial disease carrier | 30.80 | 11.63 | 13 | 29937 | 986 | 64467796 |
Angioedema | 30.74 | 11.63 | 80 | 29870 | 61741 | 64407041 |
Blood immunoglobulin E increased | 30.12 | 11.63 | 20 | 29930 | 3824 | 64464958 |
Dermatitis allergic | 29.90 | 11.63 | 36 | 29914 | 15073 | 64453709 |
Pharyngeal swelling | 29.89 | 11.63 | 23 | 29927 | 5536 | 64463246 |
Myalgia | 29.73 | 11.63 | 149 | 29801 | 158468 | 64310314 |
Forced expiratory volume decreased | 29.68 | 11.63 | 25 | 29925 | 6842 | 64461940 |
Urticaria | 29.48 | 11.63 | 141 | 29809 | 147176 | 64321606 |
Arthropathy | 28.95 | 11.63 | 10 | 29940 | 120957 | 64347825 |
Throat tightness | 28.76 | 11.63 | 44 | 29906 | 23116 | 64445666 |
Squamous cell carcinoma of the oral cavity | 28.45 | 11.63 | 10 | 29940 | 461 | 64468321 |
Nonspecific reaction | 27.64 | 11.63 | 15 | 29935 | 1988 | 64466794 |
Gingival swelling | 27.39 | 11.63 | 19 | 29931 | 3901 | 64464881 |
Essential tremor | 27.33 | 11.63 | 13 | 29937 | 1306 | 64467476 |
Oropharyngeal pain | 27.22 | 11.63 | 97 | 29853 | 88770 | 64380012 |
Antipsychotic drug level increased | 27.15 | 11.63 | 21 | 29929 | 5094 | 64463688 |
Bronchial secretion retention | 26.98 | 11.63 | 16 | 29934 | 2511 | 64466271 |
Thrombocytopenia | 26.77 | 11.63 | 39 | 29911 | 223762 | 64245020 |
Pregnancy with implant contraceptive | 26.04 | 11.63 | 13 | 29937 | 1451 | 64467331 |
Breast conserving surgery | 26.01 | 11.63 | 10 | 29940 | 595 | 64468187 |
Choking | 25.74 | 11.63 | 28 | 29922 | 10510 | 64458272 |
Systemic lupus erythematosus | 25.60 | 11.63 | 3 | 29947 | 77609 | 64391173 |
Miller Fisher syndrome | 24.72 | 11.63 | 7 | 29943 | 157 | 64468625 |
Platelet count decreased | 24.52 | 11.63 | 25 | 29925 | 167686 | 64301096 |
Micturition urgency | 24.40 | 11.63 | 27 | 29923 | 10332 | 64458450 |
Sinus operation | 24.25 | 11.63 | 13 | 29937 | 1682 | 64467100 |
Limb injury | 24.19 | 11.63 | 41 | 29909 | 23464 | 64445318 |
Dysmetropsia | 23.78 | 11.63 | 6 | 29944 | 85 | 64468697 |
Crying | 23.32 | 11.63 | 37 | 29913 | 20053 | 64448729 |
Anosmia | 23.15 | 11.63 | 18 | 29932 | 4399 | 64464383 |
Drug monitoring procedure not performed | 23.04 | 11.63 | 10 | 29940 | 812 | 64467970 |
Hallucination | 22.76 | 11.63 | 80 | 29870 | 72708 | 64396074 |
Bleeding time prolonged | 22.49 | 11.63 | 11 | 29939 | 1175 | 64467607 |
Hepatic enzyme increased | 21.84 | 11.63 | 17 | 29933 | 129926 | 64338856 |
Pain | 21.82 | 11.63 | 159 | 29791 | 553352 | 63915430 |
Angioplasty | 21.55 | 11.63 | 12 | 29938 | 1673 | 64467109 |
Neuropsychiatric symptoms | 21.49 | 11.63 | 10 | 29940 | 956 | 64467826 |
Migraine | 21.45 | 11.63 | 71 | 29879 | 62606 | 64406176 |
Abdominal rigidity | 21.39 | 11.63 | 14 | 29936 | 2613 | 64466169 |
Flashback | 21.36 | 11.63 | 7 | 29943 | 260 | 64468522 |
Anaemia | 21.24 | 11.63 | 97 | 29853 | 378583 | 64090199 |
Idiopathic orbital inflammation | 20.89 | 11.63 | 6 | 29944 | 142 | 64468640 |
Arterial spasm | 20.35 | 11.63 | 6 | 29944 | 156 | 64468626 |
Nasal disorder | 20.20 | 11.63 | 14 | 29936 | 2870 | 64465912 |
Mood swings | 20.04 | 11.63 | 32 | 29918 | 17436 | 64451346 |
Daydreaming | 19.95 | 11.63 | 9 | 29941 | 801 | 64467981 |
Irritability | 19.77 | 11.63 | 49 | 29901 | 36697 | 64432085 |
Headache | 19.65 | 11.63 | 350 | 29600 | 529117 | 63939665 |
Chorea | 19.64 | 11.63 | 12 | 29938 | 1988 | 64466794 |
Febrile neutropenia | 19.36 | 11.63 | 36 | 29914 | 187621 | 64281161 |
Ejaculation failure | 19.29 | 11.63 | 7 | 29943 | 354 | 64468428 |
Suicidal ideation | 19.00 | 11.63 | 71 | 29879 | 66471 | 64402311 |
Cervicogenic headache | 18.79 | 11.63 | 4 | 29946 | 25 | 64468757 |
Gastroenteritis aeromonas | 18.79 | 11.63 | 4 | 29946 | 25 | 64468757 |
Acquired macroglossia | 18.73 | 11.63 | 6 | 29944 | 207 | 64468575 |
Disease progression | 18.65 | 11.63 | 23 | 29927 | 141657 | 64327125 |
Sleep disorder due to a general medical condition | 18.60 | 11.63 | 21 | 29929 | 8213 | 64460569 |
Nasal discharge discolouration | 18.45 | 11.63 | 11 | 29939 | 1743 | 64467039 |
Product administered to patient of inappropriate age | 18.36 | 11.63 | 16 | 29934 | 4585 | 64464197 |
Liver function test abnormal | 18.32 | 11.63 | 65 | 29885 | 59336 | 64409446 |
Skin exfoliation | 18.27 | 11.63 | 54 | 29896 | 44831 | 64423951 |
Disturbance in attention | 18.25 | 11.63 | 51 | 29899 | 41023 | 64427759 |
Secretion discharge | 18.16 | 11.63 | 25 | 29925 | 11939 | 64456843 |
Differential white blood cell count abnormal | 18.13 | 11.63 | 11 | 29939 | 1799 | 64466983 |
Upper gastrointestinal haemorrhage | 17.94 | 11.63 | 46 | 29904 | 35174 | 64433608 |
Nail infection | 17.93 | 11.63 | 11 | 29939 | 1836 | 64466946 |
Spleen congestion | 17.91 | 11.63 | 7 | 29943 | 435 | 64468347 |
Renal failure | 17.75 | 11.63 | 36 | 29914 | 181652 | 64287130 |
Eye movement disorder | 17.63 | 11.63 | 19 | 29931 | 7060 | 64461722 |
Central obesity | 17.62 | 11.63 | 10 | 29940 | 1445 | 64467337 |
Neuropsychiatric syndrome | 17.38 | 11.63 | 5 | 29945 | 119 | 64468663 |
Psychomotor hyperactivity | 17.31 | 11.63 | 27 | 29923 | 14424 | 64454358 |
Tongue pruritus | 17.24 | 11.63 | 7 | 29943 | 481 | 64468301 |
Benign prostatic hyperplasia | 16.78 | 11.63 | 21 | 29929 | 9144 | 64459638 |
Multifocal motor neuropathy | 16.78 | 11.63 | 4 | 29946 | 44 | 64468738 |
Poor peripheral circulation | 16.68 | 11.63 | 13 | 29937 | 3187 | 64465595 |
Tendonitis | 16.57 | 11.63 | 32 | 29918 | 20250 | 64448532 |
Gastrointestinal tract irritation | 16.48 | 11.63 | 7 | 29943 | 539 | 64468243 |
Infection | 16.11 | 11.63 | 39 | 29911 | 184841 | 64283941 |
Encephalopathy | 15.64 | 11.63 | 4 | 29946 | 58815 | 64409967 |
Hyponatraemia | 15.54 | 11.63 | 120 | 29830 | 148219 | 64320563 |
Peripheral vascular disorder | 15.53 | 11.63 | 18 | 29932 | 7243 | 64461539 |
Status asthmaticus | 15.48 | 11.63 | 8 | 29942 | 960 | 64467822 |
Muscle spasms | 15.29 | 11.63 | 115 | 29835 | 140908 | 64327874 |
Pericarditis | 15.25 | 11.63 | 5 | 29945 | 62511 | 64406271 |
Urinary incontinence | 15.20 | 11.63 | 44 | 29906 | 36107 | 64432675 |
Lactic acidosis | 14.82 | 11.63 | 5 | 29945 | 61405 | 64407377 |
Bronchomalacia | 14.51 | 11.63 | 5 | 29945 | 217 | 64468565 |
Eye swelling | 14.49 | 11.63 | 32 | 29918 | 22249 | 64446533 |
Overdose | 14.43 | 11.63 | 33 | 29917 | 159533 | 64309249 |
Rhinovirus infection | 14.42 | 11.63 | 16 | 29934 | 6140 | 64462642 |
Lower respiratory tract infection | 14.40 | 11.63 | 84 | 29866 | 94530 | 64374252 |
Bladder irritation | 14.32 | 11.63 | 5 | 29945 | 226 | 64468556 |
Facial pain | 14.31 | 11.63 | 18 | 29932 | 7877 | 64460905 |
Hypotension | 14.24 | 11.63 | 111 | 29839 | 380863 | 64087919 |
Ageusia | 14.09 | 11.63 | 24 | 29926 | 13789 | 64454993 |
Pulmonary congestion | 14.09 | 11.63 | 33 | 29917 | 23847 | 64444935 |
Respiration abnormal | 14.08 | 11.63 | 16 | 29934 | 6299 | 64462483 |
Dyspnoea at rest | 14.06 | 11.63 | 16 | 29934 | 6313 | 64462469 |
Cardio-respiratory arrest | 14.00 | 11.63 | 15 | 29935 | 98378 | 64370404 |
Skin fragility | 13.94 | 11.63 | 7 | 29943 | 791 | 64467991 |
Abnormal weight gain | 13.78 | 11.63 | 10 | 29940 | 2203 | 64466579 |
Nasal septum ulceration | 13.56 | 11.63 | 3 | 29947 | 23 | 64468759 |
Platelet count increased | 13.48 | 11.63 | 28 | 29922 | 18668 | 64450114 |
Hypovolaemia | 13.35 | 11.63 | 25 | 29925 | 15461 | 64453321 |
Gastric ulcer perforation | 13.26 | 11.63 | 9 | 29941 | 1784 | 64466998 |
Reperfusion arrhythmia | 13.17 | 11.63 | 5 | 29945 | 287 | 64468495 |
Convulsive threshold lowered | 13.16 | 11.63 | 7 | 29943 | 892 | 64467890 |
Pneumonia streptococcal | 13.14 | 11.63 | 10 | 29940 | 2368 | 64466414 |
Syncope | 13.05 | 11.63 | 121 | 29829 | 157514 | 64311268 |
Blood pressure fluctuation | 12.91 | 11.63 | 4 | 29946 | 51867 | 64416915 |
Beta haemolytic streptococcal infection | 12.81 | 11.63 | 9 | 29941 | 1885 | 64466897 |
Mood altered | 12.79 | 11.63 | 25 | 29925 | 15954 | 64452828 |
Intentional product misuse | 12.73 | 11.63 | 9 | 29941 | 72286 | 64396496 |
Orthostatic hypotension | 12.62 | 11.63 | 49 | 29901 | 46689 | 64422093 |
Necrosis ischaemic | 12.57 | 11.63 | 7 | 29943 | 976 | 64467806 |
Superinfection | 12.54 | 11.63 | 12 | 29938 | 3874 | 64464908 |
Self-injurious ideation | 12.52 | 11.63 | 11 | 29939 | 3186 | 64465596 |
Drug intolerance | 12.51 | 11.63 | 45 | 29905 | 187947 | 64280835 |
White blood cell count decreased | 12.45 | 11.63 | 35 | 29915 | 157802 | 64310980 |
Contusion | 12.38 | 11.63 | 93 | 29857 | 113872 | 64354910 |
Musculoskeletal stiffness | 12.38 | 11.63 | 24 | 29926 | 123182 | 64345600 |
Locked-in syndrome | 12.36 | 11.63 | 6 | 29944 | 630 | 64468152 |
Blood creatinine increased | 12.34 | 11.63 | 28 | 29922 | 135754 | 64333028 |
Suicide attempt | 12.30 | 11.63 | 9 | 29941 | 70998 | 64397784 |
Vaginal discharge | 12.26 | 11.63 | 12 | 29938 | 3985 | 64464797 |
Derealisation | 12.25 | 11.63 | 8 | 29942 | 1487 | 64467295 |
Graft versus host disease in gastrointestinal tract | 12.15 | 11.63 | 14 | 29936 | 5598 | 64463184 |
Eosinophilia | 12.03 | 11.63 | 42 | 29908 | 38034 | 64430748 |
Hepatic cancer | 11.97 | 11.63 | 16 | 29934 | 7432 | 64461350 |
Gastric mucosa erythema | 11.96 | 11.63 | 5 | 29945 | 370 | 64468412 |
Nasal pruritus | 11.90 | 11.63 | 5 | 29945 | 375 | 64468407 |
Pancytopenia | 11.89 | 11.63 | 31 | 29919 | 143278 | 64325504 |
Violence-related symptom | 11.86 | 11.63 | 6 | 29944 | 689 | 64468093 |
Nasal congestion | 11.84 | 11.63 | 57 | 29893 | 59601 | 64409181 |
Inflammatory myofibroblastic tumour | 11.80 | 11.63 | 4 | 29946 | 165 | 64468617 |
Rhonchi | 11.76 | 11.63 | 11 | 29939 | 3452 | 64465330 |
Polyp | 11.76 | 11.63 | 15 | 29935 | 6658 | 64462124 |
None
Source | Code | Description |
---|---|---|
ATC | A07EA07 | ALIMENTARY TRACT AND METABOLISM ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS INTESTINAL ANTIINFLAMMATORY AGENTS Corticosteroids acting locally |
ATC | D07AC15 | DERMATOLOGICALS CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS CORTICOSTEROIDS, PLAIN Corticosteroids, potent (group III) |
ATC | D07CC04 | DERMATOLOGICALS CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS Corticosteroids, potent, combinations with antibiotics |
ATC | R01AD01 | RESPIRATORY SYSTEM NASAL PREPARATIONS DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE Corticosteroids |
ATC | R03AK08 | RESPIRATORY SYSTEM DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES ADRENERGICS, INHALANTS Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics |
ATC | R03AK13 | RESPIRATORY SYSTEM DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES ADRENERGICS, INHALANTS Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics |
ATC | R03AL09 | RESPIRATORY SYSTEM DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES ADRENERGICS, INHALANTS Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids |
ATC | R03BA01 | RESPIRATORY SYSTEM DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS Glucocorticoids |
FDA MoA | N0000175450 | Corticosteroid Hormone Receptor Agonists |
FDA EPC | N0000175576 | Corticosteroid |
CHEBI has role | CHEBI:35472 | anti-inflammatory drugs |
CHEBI has role | CHEBI:49167 | anti-asthmatic drugs |
CHEBI has role | CHEBI:38070 | antiarrhythmic agent |
CHEBI has role | CHEBI:50266 | Prodrugs |
MeSH PA | D018927 | Anti-Asthmatic Agents |
MeSH PA | D000893 | Anti-Inflammatory Agents |
MeSH PA | D005938 | Glucocorticoids |
MeSH PA | D006728 | Hormones |
MeSH PA | D019141 | Respiratory System Agents |
MeSH PA | D001993 | Bronchodilator Agents |
MeSH PA | D018373 | Peripheral Nervous System Agents |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Vasomotor rhinitis | indication | 8229003 | DOID:4730 |
Nasal polyp | indication | 52756005 | |
Allergic rhinitis | indication | 61582004 | |
Rhinitis | indication | 70076002 | DOID:4483 |
Asthma | indication | 195967001 | DOID:2841 |
Asthma management | indication | 406162001 | |
Severe chronic obstructive pulmonary disease | off-label use | 313299006 | |
Mycosis | contraindication | 3218000 | DOID:1564 |
Ocular hypertension | contraindication | 4210003 | DOID:9282 |
Inactive tuberculosis | contraindication | 11999007 | |
Epistaxis | contraindication | 12441001 | |
Measles | contraindication | 14189004 | DOID:8622 |
Disease caused by parasite | contraindication | 17322007 | |
Glaucoma | contraindication | 23986001 | DOID:1686 |
Acute tuberculosis | contraindication | 25629007 | |
Perforation of nasal septum | contraindication | 80142000 | |
Bacterial infectious disease | contraindication | 87628006 | |
Mycobacteriosis | contraindication | 88415009 | |
Operation on nose | contraindication | 88733004 | |
Bilateral cataracts | contraindication | 95722004 | |
Ophthalmic herpes simplex | contraindication | 186542001 | |
Disease of liver | contraindication | 235856003 | DOID:409 |
Varicella-zoster virus infection | contraindication | 309465005 | |
Adrenal cortical hypofunction | contraindication | 386584007 | DOID:10493 |
Exposure to varicella | contraindication | 444453009 | |
Nasal Trauma | contraindication | ||
Nasal Candidiasis | contraindication | ||
Nasal Septal Ulcers | contraindication | ||
Uncontrolled Bacterial Infections | contraindication | ||
Untreated Fungal Infection | contraindication |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 12.01 | acidic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Glucocorticoid receptor | Nuclear hormone receptor | AGONIST | Ki | 8.43 | DRUG MATRIX | CHEMBL | |||
Interleukin-5 | Cytokine | IC50 | 4.57 | CHEMBL | |||||
Mineralocorticoid receptor | Nuclear hormone receptor | EC50 | 8.32 | CHEMBL | |||||
Matrix metalloproteinase-9 | Enzyme | IC50 | 5.70 | CHEMBL | |||||
Probable G-protein coupled receptor 97 | GPCR | AGONIST | EC50 | 8.50 | IUPHAR | ||||
Progesterone receptor | Nuclear hormone receptor | IC50 | 7.55 | CHEMBL | |||||
Androgen receptor | Transcription factor | Ki | 5.96 | CHEMBL | |||||
Progesterone receptor | Transcription factor | Ki | 7.57 | CHEMBL | |||||
Glucocorticoid receptor | Transcription factor | IC50 | 8.54 | CHEMBL | |||||
Interleukin-5 | Unclassified | IC50 | 4.58 | CHEMBL | |||||
Interleukin-5 receptor subunit alpha | Unclassified | IC50 | 4.58 | CHEMBL |
ID | Source |
---|---|
D00689 | KEGG_DRUG |
77011-63-3 | SECONDARY_CAS_RN |
1347 | RXNORM |
C0004906 | UMLSCUI |
CHEBI:3002 | CHEBI |
CHEBI:3001 | CHEBI |
CHEMBL1200500 | ChEMBL_ID |
CHEMBL1370 | ChEMBL_ID |
DB00394 | DRUGBANK_ID |
5894 | IUPHAR_LIGAND_ID |
7059 | IUPHAR_LIGAND_ID |
4419-39-0 | SECONDARY_CAS_RN |
21700 | PUBCHEM_CID |
20469 | PUBCHEM_CID |
1167 | MMSL |
4249 | MMSL |
71834 | MMSL |
8263 | MMSL |
d00760 | MMSL |
002179 | NDDF |
004947 | NDDF |
4018793 | VANDF |
4019625 | VANDF |
D019819 | MESH_DESCRIPTOR_UI |
D001507 | MESH_DESCRIPTOR_UI |
C0004905 | UMLSCUI |
2307 | INN_ID |
116574000 | SNOMEDCT_US |
116575004 | SNOMEDCT_US |
1389007 | SNOMEDCT_US |
426017007 | SNOMEDCT_US |
5B307S63B2 | UNII |
KGZ1SLC28Z | UNII |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
BECONASEAQ | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0173-0388 | SPRAY, SUSPENSION | 42 ug | NASAL | NDA | 20 sections |
BECONASE AQ | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16590-030 | SPRAY, SUSPENSION | 42 ug | NASAL | NDA | 13 sections |
QVAR | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16590-860 | AEROSOL, METERED | 40 ug | RESPIRATORY (INHALATION) | NDA | 26 sections |
QVAR | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-1342 | AEROSOL, METERED | 80 ug | RESPIRATORY (INHALATION) | NDA | 28 sections |
QVAR | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-3033 | AEROSOL, METERED | 40 ug | RESPIRATORY (INHALATION) | NDA | 28 sections |
QVAR REDIHALER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-3459 | AEROSOL, METERED | 80 ug | RESPIRATORY (INHALATION) | NDA | 16 sections |
QVAR REDIHALER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-5031 | AEROSOL, METERED | 40 ug | RESPIRATORY (INHALATION) | NDA | 17 sections |
QVAR REDIHALER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-5032 | AEROSOL, METERED | 80 ug | RESPIRATORY (INHALATION) | NDA | 17 sections |
QVAR REDIHALER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 53002-2436 | AEROSOL, METERED | 40 ug | RESPIRATORY (INHALATION) | NDA | 16 sections |
QVAR REDIHALER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 53002-3477 | AEROSOL, METERED | 80 ug | RESPIRATORY (INHALATION) | NDA | 16 sections |
QVAR | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54868-5857 | AEROSOL, METERED | 40 ug | RESPIRATORY (INHALATION) | NDA | 14 sections |
QVAR | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54868-5858 | AEROSOL, METERED | 80 ug | RESPIRATORY (INHALATION) | NDA | 14 sections |
QVAR REDIHALER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59310-302 | AEROSOL, METERED | 40 ug | RESPIRATORY (INHALATION) | NDA | 17 sections |
QVAR REDIHALER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59310-302 | AEROSOL, METERED | 40 ug | RESPIRATORY (INHALATION) | NDA | 17 sections |
QVAR REDIHALER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59310-304 | AEROSOL, METERED | 80 ug | RESPIRATORY (INHALATION) | NDA | 17 sections |
QVAR REDIHALER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59310-304 | AEROSOL, METERED | 80 ug | RESPIRATORY (INHALATION) | NDA | 17 sections |
QNASL | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59310-406 | AEROSOL, METERED | 40 ug | NASAL | NDA | 27 sections |
QNASL | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59310-406 | AEROSOL, METERED | 40 ug | NASAL | NDA | 27 sections |
QNASL | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59310-410 | AEROSOL, METERED | 80 ug | NASAL | NDA | 27 sections |
QNASL | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59310-410 | AEROSOL, METERED | 80 ug | NASAL | NDA | 27 sections |